Tackling drug resistance: UK-China funding competition announced

16 Aug 2017 02:11 PM

A new competition for 2018 will make up to £10 million available to UK organisations to work with Chinese partners.

Next year will see a collaborative competition launched between the UK and China to develop solutions that address the threat of antimicrobial resistance.

Innovate UK is to invest up to £10 million in UK businesses, on behalf of the Department of Health. The Chinese Ministry of Science and Technology(MoST) will invest up to 60 million RMB to fund the Chinese partners.

The aim is to support novel projects that neither country would be able to conduct within the same timeframe without the other’s expertise. These should develop new products or services against antimicrobial resistance (AMR). Where appropriate, they should include clinical evaluation.

Addressing the threat of drug resistance

It has been estimated that failure to tackle drug-resistant infections will lead to at least 10 million extra deaths a year by 2050. This would cost the global economy up to $100 trillion USD.

A substantial research and innovation effort is needed to address the emergence and spread of antimicrobial resistance, and to speed up the development of new antimicrobials and supporting technologies.

What is in scope

When the call opens we will be looking for projects that:

All projects must comply with Official Development Assistance (ODA) criteria.

Competition information

Contact Gabriela Juarez Martinez, Knowledge Transfer Network, for information on events and to get notified when the competition opens by emailing gabriela.juarezmartinez@ktn-uk.org.

Sign up to our newsletter to find out about new funding opportunities.

Search for innovation funding.